Healthcare and Lifesciences Advisory Practice at PricewaterhouseCoopers
Location:
New York, New York
Industry:
Biotechnology
Work:
PricewaterhouseCoopers - New York, NY since Apr 2012
Healthcare and Lifesciences Advisory Practice
International AIDS Vaccine Initiative Nov 2000 - Mar 2012
Director New Alliances
World Health Organization May 2000 - Oct 2000
Consultant
Johns Hopkins School of Medicine 1993 - 1995
Graduate Student
Education:
Columbia University - Columbia Business School 2008 - 2010
MBA, Finance and Healthcare
The Johns Hopkins University School of Medicine 1993 - 2000
Doctor of Philosophy (PhD), Biochemistry, Cellular and Molecular Biology Program
Trinity College 1990 - 1992
B.Sc., Biology, Chemistry, International Relations
Skills:
Business Development Cross-functional Team Leadership Strategic Planning Corporate Partnership Development Due Diligence Technology Needs Analysis Technology sourcing Product Development Emerging Markets Emerging Technologies
Interests:
new technologies, investing, entrepreneurship, biotech, pharma
Your level of immunity to these new variants is primarily going to be determined by the timing since your last booster or natural infection, said Dr. Kalpana Gupta, chief of staff and chief of infectious disease at VA Boston Healthcare System. And with these newer variants coming along, it really